Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,785 | 89,004 | 87,312 | 63,027 | 47,481 |
| Marketable Securities | N/A | N/A | 6,747 | 6,208 | 3,458 |
| Receivables | 195,908 | 256,580 | 252,715 | 232,716 | 123,716 |
| Inventories | 93,997 | 100,348 | 82,156 | 106,394 | 38,943 |
| Income taxes - deferred | 37,327 | 523 | 22,206 | 7,972 | 7,399 |
| Other current assets | 443 | 961 | 8,681 | 1,817 | 876,144 |
| TOTAL | $490,947 | $471,946 | $480,767 | $429,003 | $1,108,650 |
| Non-Current Assets | |||||
| PPE Net | 238,244 | 236,034 | 230,051 | 189,272 | 84,449 |
| Intangibles | 962,291 | 797,632 | 1,054,526 | 1,235,441 | 332,483 |
| Other Non-Current Assets | 133,698 | 130,721 | 65,163 | 61,204 | 31,799 |
| TOTAL | $1,334,233 | $1,164,387 | $1,349,740 | $1,485,917 | $448,731 |
| Total Assets | $1,825,180 | $1,636,333 | $1,830,507 | $1,914,920 | $1,557,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 44,836 | 50,861 | N/A | 13,011 | N/A |
| Accounts payable and accrued liabilities | 29,842 | 50,443 | 63,888 | 66,593 | 135,508 |
| Other current liabilities | 49,293 | 13,922 | 12,477 | 24,050 | 13,273 |
| TOTAL | $219,253 | $211,329 | $179,897 | $208,156 | $1,055,924 |
| Non-Current Liabilities | |||||
| Long Term Debt | 344,420 | 637,002 | 374,110 | 327,039 | 76,999 |
| Other Non-Current Liabilities | 176,656 | 54,759 | -1,402 | 11,293 | -6,043 |
| TOTAL | $563,614 | $729,430 | $415,453 | $403,913 | $125,236 |
| Total Liabilities | $782,867 | $940,759 | $595,350 | $612,069 | $1,181,160 |
| Shareholders' Equity | |||||
| Common Shares | 1,238,584 | 1,140,008 | 1,131,761 | 1,130,404 | 263,161 |
| Retained earnings | -350,640 | -257,341 | 23,525 | 150,097 | 61,530 |
| Other shareholders' equity | 149,603 | 125,099 | 71,178 | 23,337 | 39,058 |
| TOTAL | $1,037,547 | $1,007,766 | $1,226,464 | $1,303,838 | $363,749 |
| Total Liabilities And Equity | $1,820,414 | $1,948,525 | $1,821,814 | $1,915,907 | $1,544,909 |